A Four-kallikrein Panel Predicts High-grade Cancer on Biopsy: Independent Validation in a Community Cohort Academic Article uri icon

Overview

MeSH Major

  • Kallikreins
  • Prostate-Specific Antigen
  • Prostatic Neoplasms

abstract

  • We evaluated a published model to predict biopsy outcome in men biopsied due to low percentage of free to total prostate-specific antigen. The model helps reduce unnecessary biopsies without missing an undue number of high-grade cancers.

publication date

  • March 2016

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4643413

Digital Object Identifier (DOI)

  • 10.1016/j.eururo.2015.04.028

PubMed ID

  • 25979570

Additional Document Info

start page

  • 505

end page

  • 11

volume

  • 69

number

  • 3